BAILII is celebrating 24 years of free online access to the law! Would you consider making a contribution?

No donation is too small. If every visitor before 31 December gives just £1, it will have a significant impact on BAILII's ability to continue providing free access to the law.
Thank you very much for your support!



BAILII [Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback]

United Kingdom Intellectual Property Office Decisions


You are here: BAILII >> Databases >> United Kingdom Intellectual Property Office Decisions >> Robert Momich and Michael E Infuso (Patent) [2006] UKIntelP o23306 (16 August 2006)
URL: http://www.bailii.org/uk/cases/UKIntelP/2006/o23306.html
Cite as: [2006] UKIntelP o23306

[New search] [Printable PDF version] [Help]


Robert Momich and Michael E Infuso [2006] UKIntelP o23306 (16 August 2006)

For the whole decision click here: o23306

Patent decision

BL number
O/233/06
Concerning rights in
GB0415793.9
Hearing Officer
Mr R C Kennell
Decision date
16 August 2006
Person(s) or Company(s) involved
Robert Momich and Michael E Infuso
Provisions discussed
PA 1977 Sections 1(1)(b), 1(2)
Keywords
Excluded fields (refused), Inventive step
Related Decisions
None

Summary

The invention related to an electronic system for monitoring clinical drug trials which prompted a subject to take a drug at appropriate times (medical compliance) and also generated a diary form on which the subject was required to record information. The examiner objected that the original method claims did not relate to any advance which was not excluded under section 1(2) having regard to the test in CFPH LLC’s Application [2005] EWHC 1589, [2006] RPC 5. He was however prepared to accept an amended claim, in which the medical compliance prompting was halted if the subject failed to complete a diary form, as not excluded under section 1(2), but found it to lack inventive step in the light of prior art documents relating to electronic compliance systems (mainly for monitoring a patient’s usage of prescribed drugs). The hearing officer did not accept the applicants’ argument that halting compliance monitoring for failure to complete a diary form was inventive in the context of clinical trials, and found all claims to lack inventive step. He saw nothing in the specification which could constitute a patentable advance and refused the application.



BAILII: Copyright Policy | Disclaimers | Privacy Policy | Feedback | Donate to BAILII
URL: http://www.bailii.org/uk/cases/UKIntelP/2006/o23306.html